EICAR (antiviral)
Overview of EICAR as an antiviral agent
Introduction[edit]

EICAR (5-ethynyl-1-_-D-ribofuranosylimidazole-4-carboxamide) is a synthetic compound that has been studied for its potential antiviral properties. It is primarily known for its activity against a range of RNA viruses.
Chemical Structure and Properties[edit]
EICAR is a nucleoside analog, which means it mimics the structure of natural nucleosides, the building blocks of nucleic acids. The chemical structure of EICAR includes an ethynyl group attached to the imidazole ring, which is believed to contribute to its antiviral activity.
Mechanism of Action[edit]
EICAR functions by inhibiting the enzyme inosine monophosphate dehydrogenase (IMPDH). This enzyme is crucial for the synthesis of guanosine triphosphate (GTP), a nucleotide necessary for RNA synthesis. By inhibiting IMPDH, EICAR effectively reduces the availability of GTP, thereby hindering viral replication.
Antiviral Activity[edit]
EICAR has demonstrated activity against several RNA viruses, including members of the Picornaviridae and Flaviviridae families. Its broad-spectrum antiviral activity makes it a candidate for further research in the development of antiviral therapies.
Potential Applications[edit]
The potential applications of EICAR extend to the treatment of viral infections such as those caused by hepatitis C virus (HCV) and rhinovirus. However, its clinical use is limited by its toxicity and the availability of more effective antiviral agents.
Research and Development[edit]
Research into EICAR has primarily focused on its mechanism of action and its potential as a lead compound for the development of new antiviral drugs. Studies continue to explore modifications to its structure to enhance its efficacy and reduce toxicity.
Conclusion[edit]
While EICAR itself is not used clinically, its study has provided valuable insights into antiviral drug development and the role of nucleoside analogs in inhibiting viral replication.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian